This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
2
0
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- UBS analyst Leonardo Olmos downgraded the rating for Globant S.A. (NYSE:GLOB) from Buy to Neutral, while raised the price target from $225 to $235. Globant shares fell 1.1% to close at $201.98 on Monday. See how other analysts view this stock.
- Citigroup analyst Thomas Singlehurst downgraded Stride, Inc. (NYSE:LRN) from Buy to Neutral, but increased the price target from $77 to $90. Stride shares gained 1.5% to close at $83.77 on Monday.
Full story available on Benzinga.com
Visited 2 times, 1 visit(s) today
Related posts:
- Home Run To Homewrecker – Analyst Cautious On Homebuilders, Downgrades Key Players
- Aclaris Therapeutics’ ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades
- Archer-Daniels-Midland’s Financial Figures ‘Are Too High,’ Analyst Downgrades Stock
- After 130% Surge, AMD Faces Uncertain Road Ahead: Top Analyst Says Chipmaker’s Future Shrouded In Doubt